Although there have been no direct studies confirming the interaction of NPRs with the JNK pathway in cancer, ANP has been shown to inhibit the MAPK signaling pathway activated by vascular endothelial growth factor (VEGF) through interaction with its receptor NPRA. The gene discussed is NPR1; the disease is cancer.